NAYA Biosciences spins off cancer drug business 6 months after INVO merger

Fecha de publicación: 15/04/2025
Fuente: FierceBiotech
Having picked up a pipeline of oncology drugs as part of a merger last year, NAYA Biosciences is reverting back to its original focus of fertility and spinning off the cancer business.